Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Discrepancy of care for ovarian and vulval cancer across the UK

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 18.07.18
Views: 644

Prof Sean Kehoe - University of Birmingham, Birmingham, UK

Prof Kehoe speaks with ecancer at BCGS 2018 about the variations in care provision across the UK.

He notes that some progress is the gradual improvement of care, where other discrepancies are indicators of underfunding and worsening services, and considers the reasons for the uneven provision of ovarian cancer care.

Prof Kehoe discusses the use of neo-adjuvant chemotherapy as a follow-up to the CHORUS trial, published in The Lancet.

Related videos

follow us


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation